Sigma Labs (NASDAQ:SGLB) Stock Price Up 16.4%

Share on StockTwits

Shares of Sigma Labs Inc. (NASDAQ:SGLB) shot up 16.4% during trading on Tuesday . The company traded as high as $1.15 and last traded at $1.12, 546,868 shares changed hands during trading. An increase of 348% from the average session volume of 121,941 shares. The stock had previously closed at $0.96.

SGLB has been the topic of several recent analyst reports. Benchmark upgraded shares of Sigma Labs to an “add” rating in a research report on Wednesday, November 20th. Aegis assumed coverage on shares of Sigma Labs in a research report on Friday, August 16th. They set a “buy” rating and a $2.00 price target for the company. Finally, Zacks Investment Research downgraded shares of Sigma Labs from a “hold” rating to a “sell” rating in a research report on Thursday, August 8th.

The firm has a 50 day moving average of $0.72 and a two-hundred day moving average of $0.95.

Sigma Labs (NASDAQ:SGLB) last posted its earnings results on Thursday, November 14th. The company reported ($0.12) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.09) by ($0.03). The firm had revenue of $0.17 million for the quarter. Sigma Labs had a negative return on equity of 330.63% and a negative net margin of 1,947.56%.

Sigma Labs Company Profile (NASDAQ:SGLB)

Sigma Labs, Inc develops and commercializes manufacturing and materials technologies. It offers PrintRite3D quality assurance software apps primarily for 3D printing and additive manufacturing industries. The company's products are used in advanced manufacturing technologies to assure part quality in real time as the part is being made and enhance process control practices.

Further Reading: Do back-end load funds outperform no-load funds?

Receive News & Ratings for Sigma Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sigma Labs and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.